We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

82 hedge funds and large institutions have $27.3M invested in Corbus Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.01% less ownership

Funds ownership: 1.19% → 1.19% (-0.01%)

4% less funds holding

Funds holding: 85 → 82 (-3)

13% less call options, than puts

Call options by funds: $290K | Put options by funds: $332K

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

40% less capital invested

Capital invested by funds: $45.6M → $27.3M (-$18.4M)

Holders
82
Holders Change
-3
Holders Change %
-3.53%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
24
Reduced
20
Closed
17
Calls
$290K
Puts
$332K
Net Calls
-$42K
Net Calls Change
+$57K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$761K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$275K
3
Renaissance Technologies
Renaissance Technologies
New York
+$222K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$166K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$127K

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$589K
2
Morgan Stanley
Morgan Stanley
New York
-$531K
3
TCM
Tekla Capital Management
Massachusetts
-$234K
4
HF
HRT Financial
New York
-$179K
5
VF
Virtu Financial
New York
-$164K
Name Holding Trade Value Shares
Change 		Change in
Stake
AWM
51
Aries Wealth Management
Maine
$9K -$7.23K -267 -34%
HighTower Advisors
52
HighTower Advisors
Illinois
$9K +$271 +10 +2%
GL
53
Graypoint LLC
New York
$8K – – –
PPA
54
Parametric Portfolio Associates
Washington
$7K +$9.56K +353 New
Two Sigma Advisers
55
Two Sigma Advisers
New York
$7K +$10.2K +377 New
CG
56
Cutler Group
California
$6K – – –
ML
57
McAdam LLC
Pennsylvania
$6K – – –
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$4K -$5.2K -192 -46%
HWM
59
HighMark Wealth Management
Minnesota
$3K – – –
ED
60
Exane Derivatives
France
$2.93K – – –
CHA
61
Carmichael Hill & Associates
Maryland
$2K – – –
Osaic Holdings
62
Osaic Holdings
Arizona
$2K +$596 +22 +25%
TRCT
63
Tower Research Capital (TRC)
New York
$2K +$2.25K +83 +2,767%
Toronto Dominion Bank
64
Toronto Dominion Bank
Ontario, Canada
$2K +$2.98K +110 New
CT
65
Cambridge Trust
Massachusetts
$2K +$3.6K +133 New
APA
66
American Portfolios Advisors
New York
$1.36K – – –
AWM
67
Accel Wealth Management
Iowa
$1K – – –
Federated Hermes
68
Federated Hermes
Pennsylvania
$1K – – –
IA
69
IFP Advisors
Florida
$1K – – –
TC
70
Trust Company
Kansas
$1K – – –
CA
71
CoreCap Advisors
Michigan
$1K +$677 +25 New
BNP Paribas Financial Markets
72
BNP Paribas Financial Markets
France
$191 -$2.65K -98 -91%
Bank of America
73
Bank of America
North Carolina
– -$589K -21,756 -100%
HF
74
HRT Financial
New York
– -$179K -5,874 Closed
VF
75
Virtu Financial
New York
– -$164K -5,346 Closed
1 2
3
4

CRBP Hedge Fund Activity: Q4 2021 in Review

82 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q4 2021, worth a combined $27.3M — down 40% from $45.6M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CRBP and 14 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 24 added.

The largest buyer was Citadel Advisors, adding an estimated $761K. The largest seller was Bank of America, cutting an estimated $589K.

  • 82 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q4 2021, down from 85 in Q3 2021.
  • Funds reported $27.3M of Corbus Pharmaceuticals stock for Q4 2021, down 40% quarter-over-quarter.
  • 14 funds opened new Corbus Pharmaceuticals positions in Q4 2021 and 17 closed out, a net change of -3 holders.
  • The largest Corbus Pharmaceuticals buyer in Q4 2021 was Citadel Advisors, an estimated $761K added.
  • The largest Corbus Pharmaceuticals seller in Q4 2021 was Bank of America, an estimated $589K sold.

Based on aggregated 13F filings for Q4 2021.